- Home
- BCAB vs LRE Comparison
BCAB vs LRE Comparison
Compare BCAB & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCAB | LRE |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 20.5M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BCAB | LRE |
|---|---|---|
| Price | $0.43 | $1.66 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 43.0K |
| Earning Date | 11-13-2025 | 07-30-2015 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.27 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $130,601,512.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.84 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $1.00 |
| 52 Week High | $1.43 | $2.97 |
Technical Indicators
Market Signals| Indicator | BCAB | LRE |
|---|---|---|
| Relative Strength Index (RSI) | 31.43 | 62.29 |
| Support Level | $0.40 | $1.53 |
| Resistance Level | $0.82 | $1.82 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 5.24 | 62.93 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.